WO2016015055A8 - Colon cleansing compositions - Google Patents
Colon cleansing compositions Download PDFInfo
- Publication number
- WO2016015055A8 WO2016015055A8 PCT/US2015/042298 US2015042298W WO2016015055A8 WO 2016015055 A8 WO2016015055 A8 WO 2016015055A8 US 2015042298 W US2015042298 W US 2015042298W WO 2016015055 A8 WO2016015055 A8 WO 2016015055A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- colon cleansing
- cleansing compositions
- compositions
- kits
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to compositions comprising guanylate cyclase C agonist peptides, and dosage forms, methods, and kits thereof. The compositions, dosage forms, methods and kits may be used for colon cleansing prior to colonoscopy, or in preparation for other medical, radiologic and/or surgical procedures.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462028963P | 2014-07-25 | 2014-07-25 | |
| US62/028,963 | 2014-07-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2016015055A1 WO2016015055A1 (en) | 2016-01-28 |
| WO2016015055A8 true WO2016015055A8 (en) | 2016-09-09 |
Family
ID=53777040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2015/042298 Ceased WO2016015055A1 (en) | 2014-07-25 | 2015-07-27 | Colon cleansing compositions |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2016015055A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE061954T2 (en) * | 2015-05-01 | 2023-09-28 | Ironwood Pharmaceuticals Inc | Compositions for colon cleansing and the treatment of gastrointestinal disorders |
| RU2713175C1 (en) * | 2019-02-04 | 2020-02-04 | Виктор Анатольевич Маткевич | Acid-mineral composition and enteral solution by matkevich for lavage of gastrointestinal tract and/or correction of homeostasis disorders |
| KR20220122613A (en) * | 2019-12-23 | 2022-09-02 | 주식회사 비보존 | colon laxative composition |
| CN115040512B (en) * | 2022-07-28 | 2023-06-20 | 苏州中化药品工业有限公司 | Pharmaceutical composition and preparation method thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2620153T3 (en) * | 2009-11-09 | 2017-06-27 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
| US20160213739A1 (en) * | 2011-05-11 | 2016-07-28 | Ironwood Pharmaceuticals, Inc | Treatments for disorders using guanylate cyclase c agonists |
| US9303066B2 (en) * | 2011-05-11 | 2016-04-05 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
| CA2902348C (en) * | 2013-02-25 | 2021-11-30 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
-
2015
- 2015-07-27 WO PCT/US2015/042298 patent/WO2016015055A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016015055A1 (en) | 2016-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3665181A4 (en) | Compositions and methods for decolonizing antibotic-resistant bacteria in the gut | |
| WO2016044463A3 (en) | Mk2 inhibitors and uses thereof | |
| IL273300A (en) | High dosage valbenazine formulation and compositions, methods, and kits related thereto | |
| CA2956871C (en) | Compounds active towards bromodomains | |
| WO2016073789A3 (en) | Anti-fgfr2/3 antibodies and methods using same | |
| EP3164702A4 (en) | Use of fluorescent polymers in marking compositions for the diagnostic determination of cleaning performance | |
| WO2016011306A3 (en) | Terminal modifications of polynucleotides | |
| WO2016060996A3 (en) | Interleukin-15 compositions and uses thereof | |
| EP3119432A4 (en) | Antibodies against immunogenic glycopeptides, composition comprising the same and use thereof | |
| WO2014152157A8 (en) | Methods and compositions for the generation and use of conformation-specific antibodies | |
| WO2014180889A8 (en) | Methods and compositions for the treatment of cancer | |
| WO2015011694A3 (en) | Isotopologues of smad7 antisense oligonucleotides | |
| WO2015171558A3 (en) | BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE | |
| SG11201705450SA (en) | Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases | |
| WO2016140933A3 (en) | Immediate release soluble ibuprofen compositions | |
| WO2016079110A3 (en) | Use of enzyme for cleaning | |
| WO2015200534A3 (en) | Small molecule agonists of neurotensin receptor 1 | |
| IL268997A (en) | Compositions comprising pgi2-receptor agonists and processes for the preparation thereof | |
| WO2016167944A3 (en) | Compositions and methods for treating autism | |
| WO2017075171A3 (en) | Pamam dendrimer based cest imaging agents and uses thereof | |
| WO2016094374A8 (en) | Compositions and methods for treatment of friedreich's ataxia | |
| WO2016015055A8 (en) | Colon cleansing compositions | |
| WO2017087917A3 (en) | Bicarbonate biosensors, calcium biosensors, and uses thereof | |
| EP3161490A4 (en) | COMPOSITIONS AND METHODS FOR DETECTING HUMAN PEGIVIRUS 2 (HPgV-2) | |
| EA201691792A1 (en) | PHARMACEUTICAL COMPOSITIONS BASED ON VILDAGLIPTINA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15745741 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 15745741 Country of ref document: EP Kind code of ref document: A1 |